Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Pasadena, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of Lixte Biotechnology Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lixte Biotechnology Holdings Inc market cap is $25.68M.
What is the 52-week high for Lixte Biotechnology Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lixte Biotechnology Holdings Inc 52 week high is $6.26 as of September 19, 2025.
What is the 52-week low for Lixte Biotechnology Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lixte Biotechnology Holdings Inc 52 week low is $0.64 as of September 19, 2025.
What is Lixte Biotechnology Holdings Inc stock price today?
Lixte Biotechnology Holdings Inc stock price today is $5.42.
What was Lixte Biotechnology Holdings Inc stock price yesterday?
Lixte Biotechnology Holdings Inc stock price yesterday was $5.63.
What is the PE ratio of Lixte Biotechnology Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lixte Biotechnology Holdings Inc’s P/E ratio is -4.38.
What is the Price-to-Book ratio of Lixte Biotechnology Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lixte Biotechnology Holdings Inc P/B ratio is 23.8267.
What is the 50-day moving average of Lixte Biotechnology Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lixte Biotechnology Holdings Inc 50-day moving average is $4.23.
How many employess does Lixte Biotechnology Holdings Inc has?